Prof. Amir Sonnenblick

Dr. Amir Sonnenblick MD PhD

 

Research Objectives:

The Breast Cancer Translational Research lab is aimed at contributing to the development of personalized medicine that tailors medical treatments to individual patients.

 

Moreover, we aim to identify molecular regulators and biomarkers involved in breast cancer development, survival and invasion and to elucidate mechanisms of resistance to therapies in breast cancer patients. To this end we embrace an integrated approach.

 

Our lab benefits from a direct access to clinical databases and to biological samples, including a tissue-bank, facilitating relevant and significant translational research. The laboratory also benefits from both, the strong clinical platform of the Breast Cancer Division and the cutting edge technological and scientific facilities available at the medical center.

 

The Laboratory operates to establish close collaborations between basic research scientists, bioinformaticians, oncologists, radiologists and pathologists from Israel and from worldwide leading academic and medical institutes.

 

Main Research topics:

  • The SWI/SNF complex in breast cancer (ARID1a): prognostic and predictive implications
  • STAT3 as a prognostic and predictor marker in breast cancer
  • The breast tumor microenvironment role in cancer development, progression and response to therapy
  • Dissecting the Akt/mTOR pathway in estrogen receptor positive breast cancers
  • Development novel strategies for success in breast cancer therapies

 

Grants:

  • Israel Cancer Research Fund (ICRF)
  • Israel Cancer Association (ICA)
  • Kamin- Ministry of health Collaborations

 

Contact Details:

amirson@tlvmc.gov.il

Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing, Contact us as soon as possible >>